At the news
? NEUTRALIMPACT 1/10 6-K filed Nov 2, 2026 at 10:32 ET
AstraZeneca filed a Form 6-K reporting the admission of 11,948 ordinary shares under its employee share schemes, issued between 1 October and 31 October 2026. The total shares outstanding increased to 1,551,065,237. This is a routine administrative notification with no material financial impact.
- 11,948 ordinary shares of $0.25 each were issued and admitted to trading on the London Stock Exchange Main Market.
- Shares were issued under the company's employee share schemes from 1 October 2026 to 31 October 2026.
- Total shares in issue following admission: 1,551,065,237.
- The admission was made under a block admission dated 29 January 2021.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access